17th October 2021
Keltic Pharma, part funded by several UofG scientists, will use the multi-million Euro funding to develop its research into a drug treating malaria. University of Glasgow spin-out company, Keltic Pharma, which was incorporated in February 2021, has been granted multi-million Euro funding from the European Union (EU) to further develop research into a groundbreaking new ...
30th April 2021
In collaboration with Breast Cancer Now, the University has evidence that the new drug may be beneficial in fighting breast cancer. University of Glasgow researchers, in collaboration with Breast Cancer Now, have findings which suggest that a cancer protein may be effectively treated by a new drug already being investigated for its beneficial role in ...
25th February 2021
UofG and Eli Lilly will collaborate on research aimed at helping develop new drugs to tackle four major diseases. The University of Glasgow has struck a new four-year research deal with US pharmaceutical company Eli Lilly and Company. The deal is worth £4.6m and will involve collaboration in researching the new generation of drug targets ...
